Synopsys, Inc. (NASDAQ:SNPS) Shares Purchased by Advisory Alpha LLC

Advisory Alpha LLC boosted its stake in Synopsys, Inc. (NASDAQ:SNPS) by 3.8% during the 4th quarter, HoldingsChannel reports. The fund owned 691 shares of the semiconductor company’s stock after buying an additional 25 shares during the period. Advisory Alpha LLC’s holdings in Synopsys were worth $335,000 as of its most recent SEC filing.

Several other institutional investors have also recently added to or reduced their stakes in the stock. Pacifica Partners Inc. acquired a new stake in shares of Synopsys during the third quarter worth $25,000. Kieckhefer Group LLC acquired a new stake in shares of Synopsys during the fourth quarter worth $27,000. Tsfg LLC raised its holdings in shares of Synopsys by 75.0% during the third quarter. Tsfg LLC now owns 56 shares of the semiconductor company’s stock worth $28,000 after purchasing an additional 24 shares during the period. Hazlett Burt & Watson Inc. raised its holdings in shares of Synopsys by 40.0% during the third quarter. Hazlett Burt & Watson Inc. now owns 70 shares of the semiconductor company’s stock worth $35,000 after purchasing an additional 20 shares during the period. Finally, Princeton Global Asset Management LLC acquired a new stake in shares of Synopsys in the 3rd quarter worth about $44,000. 85.47% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Synopsys

In other Synopsys news, CRO Richard S. Mahoney sold 20,838 shares of the stock in a transaction that occurred on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now owns 1,460 shares in the company, valued at $738,774.60. This trade represents a 93.45 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Insiders own 0.66% of the company’s stock.

Synopsys Price Performance

NASDAQ SNPS opened at $551.54 on Friday. The company has a 50 day simple moving average of $518.10 and a 200-day simple moving average of $524.47. The firm has a market capitalization of $85.26 billion, a price-to-earnings ratio of 37.98, a price-to-earnings-growth ratio of 3.47 and a beta of 1.12. Synopsys, Inc. has a 52-week low of $457.52 and a 52-week high of $629.38.

Analysts Set New Price Targets

A number of analysts recently weighed in on the stock. Needham & Company LLC reaffirmed a “buy” rating and issued a $640.00 price objective on shares of Synopsys in a report on Thursday, December 5th. Redburn Atlantic initiated coverage on shares of Synopsys in a report on Monday, January 13th. They issued a “buy” rating and a $600.00 price objective on the stock. Berenberg Bank initiated coverage on shares of Synopsys in a research report on Tuesday, October 15th. They issued a “buy” rating and a $660.00 target price for the company. Loop Capital initiated coverage on shares of Synopsys in a research report on Monday, November 11th. They issued a “buy” rating and a $675.00 target price for the company. Finally, Rosenblatt Securities reiterated a “buy” rating and issued a $635.00 target price on shares of Synopsys in a research report on Wednesday, December 4th. One analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $641.82.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.